» Articles » PMID: 24758388

Rutin Protects Against Cognitive Deficits and Brain Damage in Rats with Chronic Cerebral Hypoperfusion

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2014 Apr 25
PMID 24758388
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Chronic cerebral hypoperfusion is a critical causative factor for the development of cognitive decline and dementia in the elderly, which involves many pathophysiological processes. Consequently, inhibition of several pathophysiological pathways is an attractive therapeutic strategy for this disorder. Rutin, a biologically active flavonoid, protects the brain against several insults through its antioxidant and anti-inflammatory properties, but its effect on cognitive deficits and brain damage caused by chronic cerebral hypoperfusion remains unknown. Here, we investigated the neuroprotective effect of rutin on cognitive impairments and the potential mechanisms underlying its action in rats with chronic cerebral hypoperfusion.

Experimental Approach: We used Sprague-Dawley rats with permanent bilateral common carotid artery occlusion (BCCAO), a well-established model of chronic cerebral hypoperfusion. After rutin treatment for 12 weeks, the neuroprotective effect of rutin in rats was evaluated by behavioural tests, biochemical and histopathological analyses.

Key Results: BCCAO rats showed marked cognitive deficits, which were improved by rutin treatment. Moreover, BCCAO rats exhibited central cholinergic dysfunction, oxidative damage, inflammatory responses and neuronal damage in the cerebral cortex and hippocampus, compared with sham-operated rats. All these effects were significantly alleviated by treatment with rutin.

Conclusion And Implications: Our results provide new insights into the pharmacological actions of rutin and suggest that rutin has multi-targeted therapeutical potential on cognitive deficits associated with conditions with chronic cerebral hypoperfusion such as vascular dementia and Alzheimer's disease.

Citing Articles

The potential of in alleviating mild cognitive impairment: a review.

Gao H, Lu H, Fang N, Su J, Li R, Wang W Front Pharmacol. 2024; 15:1484040.

PMID: 39494343 PMC: 11528016. DOI: 10.3389/fphar.2024.1484040.


Enriched environment attenuates hippocampal theta and gamma rhythms dysfunction in chronic cerebral hypoperfusion via improving imbalanced neural afferent levels.

Zheng J, Peng S, Cui L, Liu X, Li T, Zhao Z Front Cell Neurosci. 2023; 17:985246.

PMID: 37265581 PMC: 10231328. DOI: 10.3389/fncel.2023.985246.


Forest Biomass as a Promising Source of Bioactive Essential Oil and Phenolic Compounds for Alzheimer's Disease Therapy.

Moreira P, Matos P, Figueirinha A, Salgueiro L, Batista M, Branco P Int J Mol Sci. 2022; 23(15).

PMID: 35955963 PMC: 9369093. DOI: 10.3390/ijms23158812.


Melatonin attenuates cerebral hypoperfusion-induced hippocampal damage and memory deficits in rats by suppressing TRPM7 channels.

Al Dera H, Alassiri M, Kahtani R, Eleawa S, AlMulla M, Alamri A Saudi J Biol Sci. 2022; 29(4):2958-2968.

PMID: 35531206 PMC: 9073071. DOI: 10.1016/j.sjbs.2022.01.018.


Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction.

Auxtero M, Chalante S, Abade M, Jorge R, Fernandes A Pharmaceutics. 2021; 13(1).

PMID: 33478035 PMC: 7835864. DOI: 10.3390/pharmaceutics13010124.


References
1.
Mizoguchi K, Shoji H, Tanaka Y, Maruyama W, Tabira T . Age-related spatial working memory impairment is caused by prefrontal cortical dopaminergic dysfunction in rats. Neuroscience. 2009; 162(4):1192-201. DOI: 10.1016/j.neuroscience.2009.05.023. View

2.
Levine D, Langa K . Vascular cognitive impairment: disease mechanisms and therapeutic implications. Neurotherapeutics. 2011; 8(3):361-73. PMC: 3167237. DOI: 10.1007/s13311-011-0047-z. View

3.
Yamamoto Y, Shioda N, Han F, Moriguchi S, Nakajima A, Yokosuka A . Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation. Brain Res. 2009; 1295:218-29. DOI: 10.1016/j.brainres.2009.07.081. View

4.
Tanaka K, Ogawa N, Asanuma M, Kondo Y, Nomura M . Relationship between cholinergic dysfunction and discrimination learning disabilities in Wistar rats following chronic cerebral hypoperfusion. Brain Res. 1996; 729(1):55-65. View

5.
Kume K, Hanyu H, Sato T, Hirao K, Shimizu S, Kanetaka H . Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study. J Neurol. 2011; 258(7):1295-303. DOI: 10.1007/s00415-011-5927-y. View